<div id="readability-page-1"><p>In a report released on April 13,  from Guotai Haitong maintained a Buy rating on The United Laboratories International Holdings, with a price target of <span id="expert-recommendation-target">HK$15.53</span>. The company’s shares closed yesterday at HK$9.80.</p><h3>Claim 30% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul>  <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for The United Laboratories International Holdings with a HK$16.36 average price target.</p></div>

03933

159316

159570

<p>Guotai Haitong has maintained a Buy rating on The United Laboratories International Holdings (ULIHF) with a price target of HK$15.53, while the shares closed at HK$9.80. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$16.36.</p>

Tip Ranks

UNITED LAB

E Fund Hang Seng SCHK Innovative Drug ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Penghua SSE STAR Biology and Medicine ETF

Penghua CSI HK Connect Health Care Composite ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Guotai CSI Bio-medicine ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Yinhua CSI Innovative Drugs Industry ETF

ICBCCS SSE STAR Biology and Medicine ETF

Guotai Haitong Keeps Their Buy Rating on The United Laboratories International Holdings (ULIHF)